N1,N4-DICYCLOPROPYL-2,3-DIHYDROXYSUCCINAMIDE, 95.0%, 1g

(R)-2-Azabicyclo[2.2.2]octane-3-carboxylic acid, 98+%, 100mg

Methyl 3-amino-2,2-dibenzylpropanoate, 95.0%, 1g

tert-Butyl 2-(chloromethyl)-1H-benzo[d]imidazole-1-carboxylate, 95.0%, 100mg

4-Methyl-2-pentanol>98.0%(GC)25mL

(R)-2-PHENYLPYRROLIDINE, 95.0%, 100mg

ethyl (1R,5S,6R)-2-oxobicyclo[3.1.0]hexane-6-carboxylate, 97%, 1g

2-(Heptafluoropropoxy)hexafluoropropyl Trifluorovinyl Ether>98.0%(GC)5g

Morpholine, min. 99%, for synthesis, 100 ml, glass packaging

100 ml square bottle HDPE natural OV 32 square

Z-(R,S)-3-amino-2-oxo-5-phenyl-1,4-benzodiazepine, 98.0%, 250mg

tert-Butyl 4-(propylamino)piperidine-1-carboxylate, 95.0%, 1g

N-methyl-1-(1-methyl-1H-benzimidazol-2-yl)methanamine dihydrochloride, 95.0%, 1g